Activation-induced Apoptosis of Mature T Cells is Dependent Upon the Level of Surface TCR but Not on the Presence of the CD3 Zeta ITAM
Overview
Authors
Affiliations
Activation-induced cell death (AICD) occurs primarily in recently activated T cells after a second TCR triggering. Since a threshold in the activation status may be critical for AICD, it is likely that the CD3 ITAM, docking sites for tyrosine kinases, regulate AICD. A 'threshold model' for AICD was tested by using two targeted mutant mouse strains lacking either the zeta chain (CD3zeta-/-) or the ITAM of the zeta chain (CD3zeta-/-:Tgzetadelta67-150). Although the T cells from the CD3zeta-/- mice express extremely low levels of surface TCR, a subpopulation (approximately 18%) of activated T cells could be induced to express TCR/FcepsilonRI gamma by using a powerful polyclonal activation protocol. These activated TCR/FcRI gamma T cells were capable of undergoing AICD, but its induction required 10 times as much anti-CD3epsilon mAb as that required for AICD of wild-type T cells. Thus, the intensity of AICD correlated with the level of CD3 expression and was less efficient with activated, CD3zeta(-/-)-derived T cells. By contrast, AICD of T cells from the CD3zeta-/-:Tgzetadelta67-150 mice could be induced with low doses of anti-CD3epsilon mAb and the extent of AICD was comparable to T cells from wild-type mice. The AICD induced in T cells from CD3-/-, CD3zeta-/-:Tgzetadelta67-150 and normal controls was specifically inhibited by Fas-Ig fusion proteins. Our data support the 'threshold model' of AICD by demonstrating that AICD is controlled by the strength of T cell activation.
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes.
Lee K, Epstein B, Lake C, Snow A Front Cell Death. 2023; 2.
PMID: 38074985 PMC: 10705843. DOI: 10.3389/fceld.2023.1281137.
FOXP3 protects conventional human T cells from premature restimulation-induced cell death.
Voss K, Lake C, Luthers C, Lott N, Dorjbal B, Arjunaraja S Cell Mol Immunol. 2019; 18(1):194-205.
PMID: 31659245 PMC: 7852538. DOI: 10.1038/s41423-019-0316-z.
Ruffo E, Malacarne V, Larsen S, Das R, Patrussi L, Wulfing C Sci Transl Med. 2016; 8(321):321ra7.
PMID: 26764158 PMC: 4918505. DOI: 10.1126/scitranslmed.aad1565.
Olasz K, Boldizsar F, Kis-Toth K, Tarjanyi O, Hegyi A, van Eden W Clin Exp Immunol. 2012; 167(2):346-55.
PMID: 22236012 PMC: 3278702. DOI: 10.1111/j.1365-2249.2011.04506.x.
Ortiz S, Lee W, Smith D, Forman S, Lee T, Liu C Exp Biol Med (Maywood). 2010; 235(12):1450-63.
PMID: 21127342 PMC: 3247199. DOI: 10.1258/ebm.2010.010056.